Nexus Pharmaceuticals Launches Tranexamic Acid
This milestone is another step for Nexus in its mission to provide life-saving medication to those who need it most.
Nexus Pharmaceuticals | 20/03/2025 | By Aishwarya
Nexus Pharmaceuticals Secures FDA Approval for Tacrolimus Injection
Tacrolimus Injection 5 mg/mL (Single-Dose Vial) in a 10-pack will be launching soon.
Nexus Pharmaceuticals | 15/02/2025 | By Aishwarya
Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus
Eli Lilly has signed a definitive agreement with Nexus Pharmaceuticals wherein Lilly will be acquiring a manufacturing facility from Nexus.
Nexus Pharmaceuticals | 23/04/2024 | By Aishwarya | 247
Nexus Pharmaceuticals receives FDA inspection of pharma manufacturing facility in Wisconsin
The Pleasant Prairie facility, which spans more than 84,000 square feet, is equipped with state-of-the-art isolator technology and adheres to the highest current good manufacturing practice (CGMP) standards
Nexus Pharmaceuticals | 08/05/2023 | By Sudeep Soparkar | 585
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy